News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DOV Pharmaceutical Announces Third Quarter Results


11/7/2007 2:23:08 PM

SOMERSET, NJ--(Marketwire - November 07, 2007) - DOV Pharmaceutical, Inc. ("DOV", or the "Company") (OTCBB: DOVP) (PINKSHEETS: DOVP) announced today results for the third quarter ending September 30, 2007. Third Quarter 2007 Performance For the third quarter of 2007, the Company reported a net loss attributable to common stockholders of $3.8 million, or $0.03 per share, as compared with $17.5 million, or $0.68 per share, for the comparable period in 2006. For the nine months ended September 30, 2007, the Company reported a net loss attributable to common stockholders of $6.3 million, or $0.10 per share, compared with $58.4 million, or $2.42 per share, for the comparable period in 2006. At September 30, 2007, cash and cash equivalents and marketable securities totaled $10.6 million.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES